Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.34 |
| ▸ | MGLL | Q99685 | 2/20 | 0.34 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.32 |
| ▸ | TUBB | P07437 | 1/20 | 0.32 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.32 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.32 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.32 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.32 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.32 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.32 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.32 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.32 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.32 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.32 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.32 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.32 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.32 |
| ▸ | KRAS | P01116 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23088800 | 1.00 | FAAH (0.34) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL29351838 | 1.00 | FAAH (0.34) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| Hydrochloric Acid SCHEMBL29369852 | 0.99 | FAAH (0.33) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| Hydrochloric Acid SCHEMBL29819885 | 0.99 | FAAH (0.33) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| Hydrochloric Acid SCHEMBL20241832 | 0.99 | FAAH (0.33) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| Methylamine SCHEMBL28480158 | 0.98 | FAAH (0.33) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| Methane SCHEMBL20657745 | 0.98 | FAAH (0.33) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL28376004 | 0.98 | FAAH (0.33) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL29359375 | 0.95 | FAAH (0.36) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL241113 | 0.95 | FAAH (0.36) | FAAHMGLLTUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2123 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240262934-A1 | STARCH-INDOLE-ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | SHANDONG SHANWEI IMMUNOTECH CO., LTD. (CN) | 2024-08-08 | — | — | US | claimed |
| EP-3842425-B1 | NOVEL QUINOLINE DERIVATIVE INHIBITOR | TRANSTHERA SCIENCES NANJING INC (CN) | 2024-05-22 | — | — | EP | claimed |
| US-11891602-B2 | Method of producing hairpin single-stranded RNA molecules | TORAY INDUSTRIES, INC. (JP) | 2024-02-06 | — | — | US | claimed |
| US-11827612-B2 | Hydroxamic acid derivative, method for producing same and use thereof | INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2023-11-28 | — | — | US | claimed |
| US-11702444-B2 | Method for preparing natural bioactive peptide Tubulysin U | SHENZHEN INSTITUTE OF GERIATRICS (CN) | 2023-07-18 | — | — | US | claimed |
| WO-2023105497-A1 | SYNTHESIS OF GLP-1 ANALOGUES | ANTHEM BIOSCIENCES PVT. LTD. (IN) | 2023-06-15 | — | — | WO | claimed |
| US-20230174479-A1 | CYANINE-DERIVED COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | NANJING GENVIVO BIOTECH CO., LTD. (CN) | 2023-06-08 | — | — | US | claimed |
| US-20230099436-A1 | METHOD FOR PREPARING NATURAL BIOACTIVE PEPTIDE TUBULYSIN U | SHENZHEN INSTITUTE OF GERIATRICS (CN) | 2023-03-30 | — | — | US | claimed |
| EP-4079723-A1 | CYANINE DERIVATIVE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Nanjing Genvivo Biotech Co., Ltd. (CN) | 2022-10-26 | — | — | EP | claimed |
| CN-115197090-A | Amide derivative of multi-caffeoyl quinic acid, preparation method and application thereof | 泰米西斯公司 | 2022-10-18 | — | — | CN | claimed |
| CN-113087784-A | Somalufide amino-terminal formaldehide and preparation method thereof | 齐鲁制药有限公司 | 2021-07-09 | — | — | CN | claimed |
| EP-3842425-A1 | NOVEL QUINOLINE DERIVATIVE INHIBITOR | Nanjing Transthera Biosciences Co., Ltd. (CN) | 2021-06-30 | — | — | EP | claimed |
| US-10894773-B2 | Deuterated CFTR potentiators | VERTEX PHARMACEUTICALS (EUROPE) LIMITED (GB) | 2021-01-19 | — | — | US | claimed |
| US-20200290971-A1 | DEUTERATED CFTR POTENTIATORS | VERTEX PHARMACEUTICALS (EUROPE) LIMITED (GB) | 2020-09-17 | — | — | US | claimed |
| CN-111349153-A | Preparation method of atrial natriuretic peptide | 四川吉晟生物医药有限公司 | 2020-06-30 | — | — | CN | claimed |
| CN-107531614-B | Preparation method of delogevir | 迈兰实验室有限公司 | 2020-04-10 | — | — | CN | claimed |
| CN-110964097-A | Synthesis of exenatide by solid-phase fragment method | 南京华威医药科技集团有限公司 | 2020-04-07 | — | — | CN | claimed |
| US-10479766-B2 | Deuterated CFTR potentiators | Verex Pharmaceuticals (Europe) Limited (GB) | 2019-11-19 | — | — | US | claimed |
| US-20190169129-A1 | DEUTERATED CFTR POTENTIATORS | VERTEX PHARMACEUTICALS (EUROPE) LIMITED (GB) | 2019-06-06 | — | — | US | claimed |
| US-20180086711-A1 | DEUTERATED CFTR POTENTIATORS | VERTEX PHARMACEUTICALS (EUROPE) LIMITED (GB) | 2018-03-29 | — | — | US | claimed |